<DOC>
	<DOC>NCT01623882</DOC>
	<brief_summary>The primary purpose of this study is to evaluate the safety and efficacy of the concurrent use of Apligraf速 and the SNaP速 Wound Care System for the treatment of diabetic and venous stasis lower extremity ulcers.</brief_summary>
	<brief_title>Clinical Evaluation of the Combined Use of Apligraf速 and the SNaP速 Pressure Wound Therapy System</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Wound &lt; 10 cm in greatest diameter Wound age &gt; 4 weeks and patient shows &lt; 50% wound area healing after 4 weeks of treatment Patient &gt; 18 years of age Patient is willing and able to sign consent Patient is willing and able to complete study visits and comply with study dressing protocols Wound size reduction of &gt; 50% in last 4 weeks of treatment Patients with active wound infections, including cellulitis and osteomyelitis Patients with wounds not able to have eschar debrided ABI &lt; 0.65 or SPP &lt; 30mmHg Patients with wounds in anatomic areas which preclude achieving an airtight seal for NPWT Ulcers due to inflammatory conditions such as rheumatoid arthritis, lupus, scleroderma, vasculitis, calciphylaxis, etc. Patients with allergy to or intolerance of any of the wound dressing materials expected to be used during the trial. Pregnant patients Patients unable to tolerate NPWT Patients with dialysis dependent ESRD Index ulcer is on the plantar surface of the foot</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Wounds</keyword>
	<keyword>Ulcers</keyword>
</DOC>